India Nears Completion of Phase III Dengue Vaccine Trials
This update was provided in response to a question raised by Eatala Rajender, a Member of Parliament, during a Lok Sabha session on Friday. The multi-centre trial has enrolled over 10,000 participants, with more than 70% of the enrollment completed. The study is being conducted at 20 designated research centres across India, including key sites such as JSS Medical College and Hospital in Mysore (Karnataka), Bangalore Medical College & Research Institute in Bengaluru (Karnataka), and AIIMS Bibinagar in Hyderabad (Telangana). Each site has been allocated a budget of approximately Rs 1.3 to Rs 1.5 crore.
Dengue remains a major public health challenge in India. Data from the Integrated Health Information Platform (IHIP) indicates that there were 573,563 laboratory-confirmed dengue cases reported in 2024, ranking the country among the top 30 worldwide for disease prevalence.Currently, there is no licensed antiviral treatment or vaccine available for dengue in India. The treatment protocol is supportive, following national clinical management guidelines developed by the Union Health Ministry. These guidelines have been shared with all states and Union Territories to enhance preparedness and response capabilities during outbreaks.
Given the circulation of all four dengue virus serotypes (DENV-1 to DENV-4) across different regions of India—sometimes even within the same individual—the ICMR has strategically selected trial zones that reflect this viral diversity. This method aims to assess the vaccine's broad-spectrum efficacy.
In parallel, the government is implementing efforts under the National Health Mission (NHM), which include vector control measures, fogging operations, public awareness campaigns, and improved surveillance infrastructure. Sentinel Surveillance Hospitals and Apex Laboratories have been established to facilitate free diagnosis and reporting.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Embark On A Celestial Odyssey
1 2 3 4 Lucknow: Do you wish to experience a meteor shower or a walk on the moon or planets? These and many more celestial events will soon become a virtual reality. Astronomy lovers, specially children, can embark on such celestial odysseys at the Indira Gandhi Planetarium located near Daliganj Crossing, which has been given a digital makeover with a budget of Rs 30 crore. It had been closed for two years for the renovation work. The highly advanced planetarium with 2D/3D projection systems and audiovisual special effects will be inaugurated sometime around mid-Aug. According to planetarium officials, it will offer visitors the real feel of travelling in the Milky Way under a shower of galaxies and shooting stars, akin to being an astronaut sitting in a spacecraft and observing the universe. "The upgraded planetarium has been modelled on the lines of Kolkata's Birla Planetarium. It will give a real space experience to astronomy buffs with a hi-tech audio system, the facility of accessing a library of Nasa and Easa star catalogues, an astronomical catalogue that lists stars," said an official. "The planetarium was operational from May 2003 till Feb 2023. Over 10 lakh people and students watched the shows. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Your Antivirus protection may end soon: Click here to renew McAfee Learn More Undo In the old system, stars were projected through an optomechanical projector and graphics were screened through slide projectors," he said. "The production of slides was discontinued years back, and spares of optomechanical systems were not available in the market. The quality of shows deteriorated, hence, it was decided to close the planetarium temporarily and install a new planetarium system with state-of-the-art technology," he added. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and s ilver prices in your area.
Time of India
2 hours ago
- Time of India
Inquiry panel wants FIR lodged against then Nashik Civil Hospital officials & firm for cheating govt
Nashik: A district committee led by Ashima Mittal, the then Nashik zilla parishad CEO, has uncovered irregularities amounting to Rs 11 crore in the tender process to construct a 30-bed modular ICU at Nashik Civil Hospital and a 10-bed modular ICU at Malegaon during 2021-22 and procuring of medical equipment, said Nashik civil surgeon Charudatta Shinde on Thursday. The projects were financed through Centre's Emergency Covid Response Programme-II funds. The alleged irregularities include a part payment of Rs 3.4 crore made without any provision and a payment of Rs 7.7 crore for the purchase of medical equipment — both to the same company that was not even registered with the Food and Drugs Administration. Following complaints by the then Union minister of state Bharati Pawar and Nashik Central MLA Devyani Pharande regarding the tender process, the district-level committee headed by Mittal was set up to investigate the allegations. The committee conducted its inquiry and submitted a report to the commissioner of the National Health Mission, which oversaw the construction of the ICUs. Mittal has recently been transferred to Jalna as collector. "The committee headed by the CEO in its July 23, 2025, report found that the part payment to the company was made despite there being no provisions for the same and without appropriate govt directives, for which show cause notices have to be issued to the then civil surgeon and other officials. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Meet The Lover Of Cliff Richard - Try Not To Gag Outlier Model Undo Also, the same company was engaged in the purchase of medical equipment despite not being registered with the Food and Drugs Administration and, therefore, an FIR has to be registered against it," said Charudatta Shinde. The committee noted that the company was initially awarded the construction work of the modular ICUs for Rs 9.5 crore following the tender process. However, the then commissioner of NHM questioned the work order's issuance without state approval and ordered the work to stop. A revised proposal of Rs 6.7 crore was submitted, reducing the number of cubicles instead of revising the rates. Nevertheless, the company had already received a part payment of Rs 3.4 crore. "In this case, the notice has been issued to then civil surgeon Dr Ashok Thorat and the officials concerned. Their response is expected soon," said Shinde. Additionally, the committee found that the same company supplied medical equipment worth Rs 7.7 crore through 10 different tenders without being registered with the FDA, Thane office, and had provided forged documents. "As per the reports from the FDA's Thane office, the committee has said that the company by that name is not registered. The company has provided details of another Bhiwandi-based company, which means it has forged documents and cheated govt to get the tender for supplies. Therefore, it should be blacklisted, and a criminal offence should also be registered against it. We are in the process of filing the complaint with the police," said Shinde. Dr Ashok Thorat, the then civil surgeon, said he had received the notice and would respond accordingly. "We have received the notice about the issue. We will present our say to the district committee on Monday," Dr Thorat said without commenting further. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and s ilver prices in your area.
The Print
3 hours ago
- The Print
Why 650 Haryana hospitals have halted AB-PMJAY services, in move set to hit 1.4 crore beneficiaries
The Centre's flagship health insurance scheme, AB-PMJAY, provides Rs 5 lakh annual coverage per family for secondary and tertiary hospitalisation, benefitting over 12 crore economically vulnerable families across India. Of them, 1.364 crore beneficiaries are from Haryana. The Indian Medical Association, Haryana, has declared a complete halt in the implementation of the scheme in private hospitals over pending dues estimated at Rs 500 crore. According to IMA, Haryana, nearly 650 private hospitals have not received reimbursements this quarter, and some dues have been pending for over a year now. New Delhi: Haryana private hospitals empanelled under the Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) have suspended services under the healthcare scheme, citing non-payment of reimbursements by the state government. On 6 August, at an emergency meeting with Haryana's chief secretary and senior health officials, the IMA learnt that Haryana had released Rs 145 crore and the Centre Rs 70 crore for the scheme implementation in the current quarter. Even with Rs 245 crore paid by the two governments—an IMA statement said—dues of Rs 490 crore are still pending. 'The root of the problem is the budgetary mismatch,' said Dr Suresh Arora, a senior consultant at Surya Ortho & Trauma Centre in Faridabad, which is among the private hospitals suspending services under AB-PMJAY. 'Haryana's annual budget for the scheme is nearly Rs 700 crore, but actual expenses exceed Rs 1,400–1,500 crore. This shortfall has persisted for the last three years.' His hospital alone has pending dues of Rs 20 lakh. ThePrint has learnt that another large, multi- or super-speciality hospital, the 2,600-bed Amrita Hospital, which Prime Minister Narendra Modi inaugurated in Faridabad on 24 August 2022, is yet to be reimbursed Rs 18 crore under the scheme. A total of 32,736 hospitals are empanelled under AB-PMJAY across India, including 15,024 private and 17,712 government hospitals. Haryana currently has 1,341 empanelled hospitals, according to official data. 'This has become a pattern every three months,' said Dr Dhirendar K. Soni, the secretary of IMA Haryana. 'Payments delayed, hospitals threaten to suspend services, and then a part of the money is released.' Also Read: Chhattisgarh pvt hospitals are gaming Ayushman Bharat PMJAY. It's the state with 2nd highest frauds 'Interest clause not honoured' Hospitals also allege that the Haryana government has failed to honour a key clause in the Memorandum of Understanding (MoU)—paying interest on delayed payments. The original MoU included a clause for interest payment in the case of delayed payments under the PM-JAY scheme, but states like Haryana reportedly have removed it. 'Not only is that not paid, but we are also seeing deductions in reimbursements,' said Dr Arora. 'They are rejecting cases on flimsy grounds, not offering additional payments to NABH-accredited hospitals—those certified for maintaining higher standards of care and patient safety—and in some cases, reimbursing only Rs 4,000–5,000 on bills worth Rs 18,000.' An IMA delegation, which previously met Chief Minister Nayab Singh Saini in February to raise these concerns, 'was assured of a resolution, but nothing has happened since', Dr Soni said. Dr Girdhar J. Gyani, Director-General of the Association of Healthcare Providers of India (AHPI), which represents over 15,000 private hospitals, including major chains such as Fortis, Max, Manipal, Medanta, and Apollo, pointed out two structural issues with the scheme. One issue, Gyani noted, was the lack of a strict clause in the scheme for interest payments to empanelled hospitals in the case of delays to ensure timely reimbursements by governments. 'If the one percent interest clause applied on delays beyond the 15-day agreement period, officials would be more accountable,' he said. In the current setup, the government often defaults on payments, leaving smaller hospitals grappling with severe cash flow challenges. Different states, same challenges The primary issue with the scheme, Dr Gyani said, was inadequate funds allocation. Haryana is not alone. Newly joining states such as Delhi and others, including Chhattisgarh, are also grappling with reimbursement delays and mounting dissatisfaction among private hospitals under the AB-PMJAY. Delhi has 143 empanelled hospitals, including public and private facilities. A reply to an RTI filed by activist Dr Ajay Basudev Bose in February this year revealed that dues of Rs 1,21,61,45,63,617 under the scheme are pending across India. Earlier, ThePrint reported that several large hospital chains were reluctant to join the scheme due to consistent non-payment. Dr Gyani said that several states, including Tamil Nadu, Andhra Pradesh, Telangana, Maharashtra, and Gujarat, had expanded the coverage under AB-PMJAY, surpassing the number of socio-economically eligible beneficiaries initially identified under the national guidelines. Now, these states are supposed to bear the excess coverage costs from their treasury, but many, however, do not have the funds, he added. Dr Gyani also raised concerns about the Central Government Health Scheme (CGHS), which offers highly subsidised healthcare, mainly private healthcare, to central government employees and pensioners. 'CGHS [core] rates have not been revised since 2014, despite inflation. The government is now proposing a new agreement, with more stringent conditions, but without updating the rates,' he said. Many hospitals would likely withdraw from CGHS, as well, if the government approved the conditions but did not update the rates, he added. (Edited by Madhurita Goswami) Also Read: No doctor or ICU—small pvt hospitals drive AB-PMJAY fund misuse in Chhattisgarh as monitoring lax
